Skip to content
Biodatica
Start free

Investigator

Li Ma

UNIVERSITY OF TX MD ANDERSON CAN CTR · funded by NCI, NIGMS

Companies
1

Resolved onto their grants.

Grants
4

Federal awards on file.

Non-dilutive funding
$1.8M

Summed across those awards.

First award
Sep 15, 2020

Latest Jun 10, 2025.

Companies from this work

Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.

Grant record

Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.

  1. R01

    Study of a new driver and therapeutic vulnerability of bone metastasis

    $565k

    Jun 10, 2025NCIUNIVERSITY OF TX MD ANDERSON CAN CTRNIH RePORTER · 11201506 (opens the source filing in a new tab)

  2. R01

    Study of a new driver and therapeutic vulnerability of bone metastasis

    $565k

    Jun 10, 2025NCIUNIVERSITY OF TX MD ANDERSON CAN CTRNIH RePORTER · 11355489 (opens the source filing in a new tab)

  3. R01

    Targeting the LIFR-LCN2 pathway to improve liver cancer therapy

    $480k

    Jan 1, 2023NCIUNIVERSITY OF TX MD ANDERSON CAN CTRNIH RePORTER · 11250016 (opens the source filing in a new tab)

  4. R01

    Statistical modeling of cross-sample variation and learning of latent structures in microbiome sequencing data.

    $169k

    Sep 15, 2020NIGMSUNIVERSITY OF CHICAGONIH RePORTER · 11325218 (opens the source filing in a new tab)

This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources